Focus on gastrointestinal bleeding (melena, hematemesis), intra-abdominal bleeding, and puncture-site bleeding for bleeding monitoring; regularly test prothrombin time, INR, and platelet count; and assess risk factors (active ulcers, portal hypertension). This evidence concerns the gene F2 and portal hypertension.